Background
Amelia is a Trainee Patent Attorney in the Dehns Biotechnology Group. She joined the Dehns London Office in September 2023.
Prior to starting at Dehns, Amelia completed an MSc in Genomics with distinction at the University of Southampton. For her dissertation project, she worked with the AI-driven drug discovery company Evariste to investigate novel therapeutic treatments for oesophageal adenocarcinoma. Before this, Amelia graduated from the University of Southampton with a first-class BSc degree in Biochemistry, with her final project focusing on devising a drug development business plan.
Type of clients and client work
Amelia has worked with a range of clients, from small-to-medium-sized businesses and sole inventors to larger companies. She has gained experience working in multiple jurisdictions, such as the EPO, the UK, the US, Australia, Brazil, Canada, China, India, and Japan, with the majority of her work concerning the filing and prosecution of patent applications.
Expertise
Amelia has worked on a variety of technologies in the fields of biochemistry and biotechnology, including inventions related to nucleic acid detection and amplification, modulation of gene expression, therapeutic uses of pharmaceutical compositions, immunology, and oncology.
Qualifications and Memberships
- Postgraduate Certificate in Intellectual Property Law, Bournemouth University, 2024
- Student Member of the Chartered Institute of Patent Attorneys (CIPA)
Higher Education
MSc Genomics, University of Southampton, 2023
BSc (Hons) Biochemistry, University of Southampton, 2022
Department
biotechnology